Novartis' Fabhalta receives FDA approval for C3 glomerulopathy, expanding its kidney disease portfolio as global regulatory ...
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal ...
Chronic kidney disease (CKD) is defined as a progressive loss of renal function that lasts for more than 3 months, and is classified according to the degree of kidney damage – measured by the le ...
Fibroblast activating protein inhibitor (FAPI) PET/CT imaging may be a non-invasive modality to monitor IgA nephropathy (IgAN) progression, preliminary study results suggest.
NASA astronauts could face 'life altering' changes to their bodies after being left stranded in space following a capsule ...
Health and Me on MSN12 天
Urologist Shares 'Itchy And Ugly' Symptoms Of Kidney Diseases Visible On Your SkinYour skin might be telling you something serious! Unexplained itching, discoloration, or extreme dryness could be hidden ...
A new Canadian study has found that chronic kidney disease (CKD) is linked to lower cognitive performance, affecting ...
Christopher Byers, DVM, delivered a session on CKD in cats at the 2025 Fetch Charlotte conference in North Carolina ...
Certain foods are bad for your health if you have kidney disease. Healthy kidneys regulate the body’s mineral and protein levels. But kidney disease causes progressive damage that interferes with ...
18 天
Clinical Trials Arena on MSNBiogen begins dosing in trial of felzartamab for kidney transplant patients with AMRIn Part A of the trial, subjects will be given nine intravenous infusions of either the drug or placebo over a six-month period.
Dwyane Wade is opening up about the changes in his body that he noticed prior to being diagnosed with kidney cancer. The retired NBA pro revealed in an exclusive interview aired March 11 on TODAY ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果